The Sugar Babies Study
Not Applicable
Active, not recruiting
- Conditions
- eonatal hypoglycaemiaNeonatal hypoglycaemiaMetabolic and Endocrine - Normal metabolism and endocrine development and function
- Registration Number
- ACTRN12608000623392
- Lead Sponsor
- niversity of Auckland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 230
Inclusion Criteria
Babies at risk of hypoglycaemia will be recuited to the study. However, only babies who become hypoglycaemic (blood glucose level <2.6mM) will be randomised to treatment.
Exclusion Criteria
Serious congential malformations, Terminal conditions, Abnormalities of the skin or lesions that will prevent application of the continuous glucose monitor.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular absorption mechanisms enable buccal dextrose gel to elevate neonatal blood glucose levels in ACTRN12608000623392?
How does buccal 40% dextrose gel compare to intravenous glucose in managing neonatal hypoglycemia for term infants?
Which metabolic biomarkers correlate with sustained glycemic response to dextrose gel in ACTRN12608000623392 participants?
What adverse events are associated with buccal dextrose administration in neonates with hypoglycemia, and how are they mitigated?
Are there alternative glucose formulations or combination therapies that enhance efficacy for neonatal hypoglycemia beyond dextrose gel?